Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs Moleculin Biotech, Inc. (MBRX)

AEON Biopharma, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Moleculin Biotech, Inc. are of similar size ($9.4M and $9.2M). AEON Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 8 metrics below, AEON Biopharma, Inc. leads on 4 and Moleculin Biotech, Inc. on 4.

Valuation

Metric AEON MBRX Biotechnology median
P/E n/m 0.04 10.60
P/S n/m n/m 9.40
P/B n/m 0.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.16 0.66
EV/Sales n/m n/m 9.02
Earnings yield (2,455.56%) 2,530.42% (32.88%)
Free cash flow yield (150.03%) (1,010.33%) (23.13%)

Profitability

Metric AEON MBRX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% (1,471.05%) (51.96%)
Return on assets (621.70%) (152.41%) (46.06%)
Return on invested capital 0.00% (417.27%) 0.00%

Growth

Metric AEON MBRX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (105.42%) 82.01% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON MBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 0.94 4.97
Net debt to EBITDA (2.48) 0.35 1.01

Dividend

Metric AEON MBRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON MBRX Biotechnology median
Market cap 9.35m 9.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack